News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Russia’s Pharmstandard Allocates $12 Million for its Kursk Plant Modernization
May 12, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Russia's largest pharmaceutical manufacturer, Pharmstandard, has pledged to invest Rb330 million ($12 million) into the modernisation of its facility in Kursk, a city 530 kilometres south-west of Moscow.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
Asia
Europe
MORE ON THIS TOPIC
Manufacturing
Novartis unveils North Carolina API plant as final piece of $23B US expansion
May 1, 2026
·
2 min read
·
Nick Paul Taylor
Earnings
Moderna beats revenue expectations with $389M, but litigation dogs earnings
May 1, 2026
·
3 min read
·
Annalee Armstrong
Earnings
Amgen positions MariTide as potential ‘best monthly’ obesity drug
May 1, 2026
·
2 min read
·
Tristan Manalac
Earnings
Merck drops early-stage TROP ADC, keeps deal doors open as Keytruda clock ticks
April 30, 2026
·
5 min read
·
Gabrielle Masson
